- Home
- DAKT vs INM Comparison
DAKT vs INM Comparison
Compare DAKT & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAKT
- INM
- Stock Information
- Founded
- DAKT 1968
- INM 1981
- Country
- DAKT United States
- INM Canada
- Employees
- DAKT N/A
- INM N/A
- Industry
- DAKT Office Equipment/Supplies/Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- DAKT Industrials
- INM Health Care
- Exchange
- DAKT Nasdaq
- INM Nasdaq
- Market Cap
- DAKT N/A
- INM 3.2M
- IPO Year
- DAKT 1994
- INM N/A
- Fundamental
- Price
- DAKT $13.95
- INM $2.33
- Analyst Decision
- DAKT Strong Buy
- INM
- Analyst Count
- DAKT 1
- INM 0
- Target Price
- DAKT $26.00
- INM N/A
- AVG Volume (30 Days)
- DAKT 213.7K
- INM 46.6K
- Earning Date
- DAKT 06-25-2025
- INM 05-13-2025
- Dividend Yield
- DAKT N/A
- INM N/A
- EPS Growth
- DAKT N/A
- INM N/A
- EPS
- DAKT 0.04
- INM N/A
- Revenue
- DAKT $799,806,000.00
- INM $4,832,013.00
- Revenue This Year
- DAKT N/A
- INM N/A
- Revenue Next Year
- DAKT $4.86
- INM N/A
- P/E Ratio
- DAKT $382.01
- INM N/A
- Revenue Growth
- DAKT N/A
- INM N/A
- 52 Week Low
- DAKT $10.24
- INM $1.72
- 52 Week High
- DAKT $19.89
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- DAKT 67.70
- INM 34.09
- Support Level
- DAKT $12.37
- INM $2.70
- Resistance Level
- DAKT $12.80
- INM $3.20
- Average True Range (ATR)
- DAKT 0.37
- INM 0.23
- MACD
- DAKT 0.20
- INM -0.05
- Stochastic Oscillator
- DAKT 95.77
- INM 5.26
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.